{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:33:17Z","timestamp":1793043197080,"version":"4.5.0"},"reference-count":208,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.euroneuro.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T04:35:52Z","timestamp":1710477352000},"page":"57-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Identification and treatment of individuals with childhood-onset and early-onset schizophrenia"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7254-5646","authenticated-orcid":false,"given":"Christoph U.","family":"Correll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-2944","authenticated-orcid":false,"given":"Birgitte","family":"Fagerlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1592-7656","authenticated-orcid":false,"given":"Silvana","family":"Galderisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4471-8618","authenticated-orcid":false,"given":"Martien J.","family":"Kas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2024.02.005_bib0001","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/0706743717720197","article-title":"Canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth","volume":"62","author":"Abidi","year":"2017","journal-title":"Can. J. Psychiatry Rev. Can. Psychiatr."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0002","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11920-009-0024-y","article-title":"The genetics of childhood-onset schizophrenia: when madness strikes the prepubescent","volume":"11","author":"Addington","year":"2009","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0003","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/cap.2021.0092","article-title":"Clozapine for management of childhood and adolescent-onset schizophrenia: a systematic review and meta-analysis","volume":"32","author":"Adnan","year":"2022","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0004","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/mp.2013.59","article-title":"High rate of disease-related copy number variations in childhood onset schizophrenia","volume":"19","author":"Ahn","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0005","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.3399\/BJGP.2021.0678","article-title":"Young people who have fallen through the mental health transition gap: a qualitative study on primary care support","volume":"72","author":"Appleton","year":"2022","journal-title":"Br. J. Gen. Pract. J. R. Coll. Gen. Pract."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.euroneuro.2022.04.005","article-title":"The transition from adolescence to adulthood in patients with schizophrenia: challenges, opportunities and recommendations","volume":"59","author":"Arango","year":"2022","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0007","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00787-019-01425-2","article-title":"Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis","volume":"29","author":"Arango","year":"2020","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0009","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1176\/appi.ajp.2016.15070878","article-title":"concurrent and sustained cumulative effects of adolescent marijuana use on subclinical psychotic symptoms","volume":"173","author":"Bechtold","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0010","doi-asserted-by":"crossref","first-page":"s116","DOI":"10.1192\/bjp.187.48.s116","article-title":"Early intervention and recovery for young people with early psychosis: consensus statement","volume":"48","author":"Bertolote","year":"2005","journal-title":"Br. J. Psychiatry. Suppl."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0011","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1192\/S0007125000297663","article-title":"Early intervention in psychosis. The critical period hypothesis","volume":"172","author":"Birchwood","year":"1998","journal-title":"Br. J. Psychiatry. Suppl."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0012","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00787-006-0542-7","article-title":"Comparative study of neuropsychological correlates in schizophrenia with onset in childhood, adolescence and adulthood","volume":"15","author":"Biswas","year":"2006","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0013","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1017\/S0033291712001535","article-title":"Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses","volume":"43","author":"Bombin","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0014","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.schres.2022.06.006","article-title":"Machine learning for prediction of schizophrenia using genetic and demographic factors in the UK biobank","volume":"246","author":"Bracher-Smith","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/08039488.2020.1769186","article-title":"Subjective health-related quality of life in community-dwelling middle-aged and older adults with early-onset schizophrenia","volume":"74","author":"Brink","year":"2020","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0016","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.euroneuro.2020.03.010","article-title":"Persistent negative symptoms in recent-onset psychosis: relationship to treatment response and psychosocial functioning","volume":"34","author":"Bucci","year":"2020","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0017","first-page":"116","article-title":"Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics: a network meta-analysis of randomized controlled trials","volume":"22","author":"Burschinski","year":"2023","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0018","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00787-020-01668-4","article-title":"Cognitive reserve in patients with first-episode psychosis as outcome predictor at 5-year follow-up","volume":"30","author":"Camprodon-Boadas","year":"2021","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0019","doi-asserted-by":"crossref","first-page":"505","DOI":"10.31887\/DCNS.2014.16.4\/mcarbon","article-title":"Clinical predictors of therapeutic response to antipsychotics in schizophrenia","volume":"16","author":"Carbon","year":"2014","journal-title":"Dialog. Clin. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.euroneuro.2024.02.005_bib0020","first-page":"38","article-title":"Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia","volume":"19","author":"Carbon","year":"2014","journal-title":"CNS Spectr."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0022","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/schbul\/sbac041","article-title":"Maintenance Treatment With Antipsychotic Drugs in Schizophrenia: a Cochrane Systematic Review and Meta-analysis","volume":"48","author":"Ceraso","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0023","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/chi.0b013e318054678d","article-title":"Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-term functional outcome","volume":"46","author":"Cervellione","year":"2007","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0024","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-244X-12-150","article-title":"A systematic review of the long-term outcome of early onset schizophrenia","volume":"12","author":"Clemmensen","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00787-018-1213-1","article-title":"Identifying core components and indicators of successful transitions from child to adult mental health services: a scoping review","volume":"29","author":"Cleverley","year":"2020","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0026","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1176\/appi.ajp.2009.09030311","article-title":"Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients","volume":"166","author":"Compton","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/chi.0b013e31815b5cb1","article-title":"Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes","volume":"47","author":"Correll","year":"2008","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0028","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40263-022-00932-2","article-title":"A guideline and checklist for initiating and managing clozapine treatment in patients with treatment-resistant Schizophrenia","volume":"36","author":"Correll","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0029","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.chi.0000220851.94392.30","article-title":"Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents","volume":"45","author":"Correll","year":"2006","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0030","first-page":"244","article-title":"Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review","volume":"20","author":"Correll","year":"2021","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0031","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamapsychiatry.2018.0623","article-title":"comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression","volume":"75","author":"Correll","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.02.005_bib0032","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1469-7610.2010.02235.x","article-title":"Research in people with psychosis risk syndrome: a review of the current evidence and future directions","volume":"51","author":"Correll","year":"2010","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0033","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41537-021-00192-x","article-title":"Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics","volume":"8","author":"Correll","year":"2022","journal-title":"Schizophr. Heidelb. Ger."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0034","first-page":"149","article-title":"What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?","volume":"17","author":"Correll","year":"2018","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0035","first-page":"248","article-title":"Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors","volume":"21","author":"Correll","year":"2022","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0036","first-page":"1","article-title":"Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-na\u00efve vs. previously treated adolescents with an acute exacerbation of Schizophrenia","volume":"65","author":"Correll","year":"2022","journal-title":"Eur. Psychiatry J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2013.04.018","article-title":"Early antipsychotic response to aripiprazole in adolescents with schizophrenia: predictive value for clinical outcomes","volume":"52","author":"Correll","year":"2013","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0038","first-page":"129","article-title":"Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review","volume":"22","author":"Cortese","year":"2023","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0039","doi-asserted-by":"crossref","first-page":"e01495","DOI":"10.1002\/brb3.1495","article-title":"Early and very early-onset schizophrenia compared with adult-onset schizophrenia: french FACE-SZ database","volume":"10","author":"Coulon","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/eip.12514","article-title":"Early intervention in psychosis: from clinical intervention to health system implementation","volume":"12","author":"Csillag","year":"2018","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0041","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/brainsci11020275","article-title":"A neurodevelopment approach for a transitional model of early onset schizophrenia","volume":"11","author":"De Berardis","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0042","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.schres.2012.10.026","article-title":"Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia","volume":"143","author":"de la Serna","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0043","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/a-1625-6388","article-title":"An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, crp, and clozapine levels","volume":"55","author":"de Leon","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0044","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/add.14186","article-title":"Commentary on Degenhardt et al. (2018): cause or consequence? Disentangling the relationship between psychosis and substance use","volume":"113","author":"DeVylder","year":"2018","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0045","doi-asserted-by":"crossref","first-page":"14005","DOI":"10.1038\/npjschz.2014.5","article-title":"Predictors of outcome in early-onset psychosis: a systematic review","volume":"1","author":"D\u00edaz-Caneja","year":"2015","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0046","doi-asserted-by":"crossref","DOI":"10.47626\/1516-4446-2023-3126","article-title":"Treatment resistance in schizophrenia: a meta-analysis of prevalences and correlates","author":"Diniz","year":"2023","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0047","first-page":"13","article-title":"Treatment engagement of individuals experiencing mental illness: review and update","volume":"15","author":"Dixon","year":"2016","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0048","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/schbul\/sbx197","article-title":"Negative symptoms in early-onset psychosis and their association with antipsychotic treatment failure","volume":"45","author":"Downs","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0049","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.chc.2013.04.001","article-title":"Childhood onset schizophrenia and early onset schizophrenia spectrum disorders","volume":"22","author":"Driver","year":"2013","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.chc.2019.08.017","article-title":"Childhood-onset schizophrenia and early-onset schizophrenia spectrum disorders: an update","volume":"29","author":"Driver","year":"2020","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0053","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1017\/S0033291720000409","article-title":"Differential effects of age at illness onset on verbal memory functions in antipsychotic-na\u00efve schizophrenia patients aged 12-43 years","volume":"51","author":"Fagerlund","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0054","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/FTD.0000000000000685","article-title":"Dose-related concentrations of neuroactive\/psychoactive drugs expected in blood of children and adolescents","volume":"42","author":"Fekete","year":"2020","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0055","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3389\/fgene.2019.01137","article-title":"Childhood-onset schizophrenia: a systematic overview of its genetic heterogeneity from classical studies to the genomic era","volume":"10","author":"Fernandez","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0056","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neubiorev.2010.07.001","article-title":"The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis","volume":"35","author":"Fett","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0057","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/schbul\/sbi014","article-title":"Long-term course of adolescent schizophrenia","volume":"31","author":"Fleischhaker","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0058","first-page":"1","article-title":"The report of the joint WPA\/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia","author":"Fountoulakis","year":"2020","journal-title":"CNS Spectr."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0059","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.schres.2013.11.018","article-title":"Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study","volume":"152","author":"Fraguas","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0060","first-page":"79","article-title":"Cognitive function in early onset schizophrenia: a selective review","volume":"3","author":"Frangou","year":"2010","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0061","series-title":"Massachusetts General Hospital Comprehensive Clinical Psychiatry","article-title":"Psychosis and schizophrenia","author":"Freudenreich","year":"2016"},{"issue":"7","key":"10.1016\/j.euroneuro.2024.02.005_bib0062","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamapsychiatry.2019.4779","article-title":"Prevention of psychosis: advances in detection, prognosis, and intervention","volume":"77","author":"Fusar-Poli","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0063","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0920-9964(01)00328-0","article-title":"Neurocognition and community outcome in schizophrenia: long-term predictive validity","volume":"59","author":"Fujii","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0064","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.euroneuro.2012.04.019","article-title":"Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial","volume":"23","author":"Galderisi","year":"2013","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0065","first-page":"275","article-title":"The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia","volume":"13","author":"Galderisi","year":"2014","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0066","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1192\/j.eurpsy.2023.24","article-title":"Exercise to treat psychopathology and other clinical outcomes in schizophrenia: a systematic review and meta-analysis","volume":"66","author":"Gallardo-G\u00f3mez","year":"2023","journal-title":"Eur. Psychiatry J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0067","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0068","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0069","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00127-022-02238-6","article-title":"Demographic, clinical, and service-use characteristics related to the clinician's recommendation to transition from child to adult mental health services","volume":"57","author":"Gerritsen","year":"2022","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.schres.2017.05.011","article-title":"An overview of medical risk factors for childhood psychosis: implications for research and treatment","volume":"192","author":"Giannitelli","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0071","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.schres.2005.04.002","article-title":"IQ stabilization in childhood-onset schizophrenia","volume":"77","author":"Gochman","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0072","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/schbul\/sbr030","article-title":"Age of onset of schizophrenia: perspectives from structural neuroimaging studies","volume":"37","author":"Gogtay","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0073","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.3390\/ijerph18147239","article-title":"A Multicentre, randomised, controlled trial of a combined clinical treatment for first-episode psychosis","volume":"18","author":"Gonz\u00e1lez-Ortega","year":"2021","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib219","doi-asserted-by":"crossref","first-page":"20r13272","DOI":"10.4088\/JCP.20r13272","article-title":"Outcomes of neuroleptic malignant syndrome with depot versus oral antipsychotics: a systematic review and pooled, patient-level analysis of 662 case reports","volume":"82","author":"Guinart","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.02.005_bib0074","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/acps.13359","article-title":"A systematic review and pooled, patient-level analysis of predictors of mortality in neuroleptic malignant syndrome","volume":"144","author":"Guinart","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.euroneuro.2024.02.005_bib0075","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/schbul\/sbab062","article-title":"Risk factors, incidence, and outcomes of neuroleptic malignant syndrome on long-acting injectable vs oral antipsychotics in a nationwide schizophrenia cohort","volume":"47","author":"Guinart","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0076","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1024\/1422-4917\/a000505","article-title":"Non-adherence to psychotropic medication among adolescents - a systematic review of the literature","volume":"46","author":"H\u00e4ge","year":"2018","journal-title":"Z. Kinder. Jugendpsychiatr. Psychother."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0077","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/jamapsychiatry.2021.0015","article-title":"Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia: a Systematic Review and Meta-analysis","volume":"78","author":"Hagi","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0078","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/2045125318765725","article-title":"Dilemmas in the treatment of early-onset first-episode psychosis","volume":"8","author":"Hayes","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0079","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.biopsych.2017.08.017","article-title":"Heritability of schizophrenia and schizophrenia spectrum based on the nationwide danish twin register","volume":"83","author":"Hilker","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0080","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ebiom.2017.04.002","article-title":"Is an early age at illness onset in schizophrenia associated with increased genetic susceptibility? Analysis of data from the nationwide danish twin register","volume":"18","author":"Hilker","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0081","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","article-title":"Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis","volume":"4","author":"Hjorth\u00f8j","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0082","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/jamapsychiatry.2021.3452","article-title":"Limitations in research on maintenance treatment for individuals with schizophrenia","volume":"79","author":"H\u00f8jlund","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0083","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S2215-0366(21)00078-X","article-title":"Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials","volume":"8","author":"H\u00f8jlund","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0084","first-page":"52","article-title":"Neurocognition in early-onset schizophrenia and schizoaffective disorders","volume":"49","author":"Hooper","year":"2010","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0086","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.biopsych.2022.06.017","article-title":"Integrating the neurodevelopmental and dopamine hypotheses of schizophrenia and the role of cortical excitation-inhibition balance","volume":"92","author":"Howes","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0087","first-page":"75","article-title":"The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis","volume":"20","author":"Howes","year":"2021","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0088","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00787-018-1242-9","article-title":"Gender differences in the prevalence, comorbidities and antipsychotic prescription of early-onset schizophrenia: a nationwide population-based study in Taiwan","volume":"28","author":"Hsu","year":"2019","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0089","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0090","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.drugalcdep.2018.07.011","article-title":"Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: systematic review and meta-analysis","volume":"191","author":"Hunt","year":"2018","journal-title":"Drug Alcohol. Depend"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0091","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/eip.13174","article-title":"Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia","volume":"16","author":"Iasevoli","year":"2022","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0092","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/eip.12412","article-title":"Age at onset and the outcomes of schizophrenia: a systematic review and meta-analysis","volume":"11","author":"Immonen","year":"2017","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0094","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00127-004-0804-y","article-title":"Adult quality of life and associated factors in adolescent onset schizophrenia and affective psychotic disorders","volume":"39","author":"Jarbin","year":"2004","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","article-title":"Schizophrenia","volume":"399","author":"Jauhar","year":"2022","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0096","article-title":"Factors differentiating childhood-onset and adolescent-onset schizophrenia:a claims database study","volume":"18","author":"Jerrell","year":"2016","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0097","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1176\/ajp.112.8.599","article-title":"Genetic aspects of preadolescent schizophrenia","volume":"112","author":"Kallmann","year":"1956","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0098","first-page":"216","article-title":"Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies","volume":"12","author":"Kane","year":"2013","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0099","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1176\/appi.ajp.2015.15050632","article-title":"Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program","volume":"173","author":"Kane","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0100","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1017\/S0033291711002960","article-title":"Prevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies","volume":"42","author":"Kelleher","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0101","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.schres.2011.06.017","article-title":"A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia","volume":"132","author":"Khandaker","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0102","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2215-0366(21)00039-0","article-title":"Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies","volume":"8","author":"Kishimoto","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0103","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/14740338.2020.1770224","article-title":"Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic review","volume":"19","author":"Kloosterboer","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0104","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.schres.2023.04.012","article-title":"The effect of exercise on global, social, daily living and occupational functioning in people living with schizophrenia: a systematic review and meta-analysis","volume":"256","author":"Korman","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0105","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/eip.12950","article-title":"Worldwide implementation of clinical services for the prevention of psychosis: the IEPA early intervention in mental health survey","volume":"14","author":"Kotlicka-Antczak","year":"2020","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0106","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamapsychiatry.2020.3604","article-title":"Multimodal machine learning workflows for prediction of psychosis in patients with clinical high-risk syndromes and recent-onset depression","volume":"78","author":"Koutsouleris","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0107","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.euroneuro.2018.03.008","article-title":"Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: a network meta-analysis","volume":"28","author":"Krause","year":"2018","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0108","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00406-018-0869-3","article-title":"Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis","volume":"268","author":"Krause","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0109","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0920-9964(03)00067-7","article-title":"The maudsley early-onset schizophrenia study: cognitive function in adolescent-onset schizophrenia","volume":"65","author":"Kravariti","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0110","article-title":"Atypical antipsychotics for psychosis in adolescents","volume":"CD009582","author":"Kumar","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0111","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.biopsych.2007.04.043","article-title":"Clozapine and \u201chigh-dose\u201d olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison","volume":"63","author":"Kumra","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0112","first-page":"1","article-title":"Developmental trajectories of premorbid functioning predict cognitive remediation treatment response in first-episode schizophrenia","author":"Kuo","year":"2022","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0113","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.3390\/ijerph18116099","article-title":"Schizophrenia: a survey of artificial intelligence techniques applied to detection and classification","volume":"18","author":"Lai","year":"2021","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.02.005_bib0114","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaac.2021.07.593","article-title":"Systematic review and meta-analysis: psychosis risk in children and adolescents with an at-risk mental state","volume":"61","author":"L\u00e5ng","year":"2022","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archgenpsychiatry.2011.5","article-title":"Cannabis use and earlier onset of psychosis: a systematic meta-analysis","volume":"68","author":"Large","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0116","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jamapsychiatry.2021.2130","article-title":"Examination of dosing of antipsychotic drugs for relapse prevention in patients with stable schizophrenia: a meta-analysis","volume":"78","author":"Leucht","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0117","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S2215-0366(22)00304-2","article-title":"The response of subgroups of patients with schizophrenia to different antipsychotic drugs: a systematic review and meta-analysis","volume":"9","author":"Leucht","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0118","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2019.19010034","article-title":"Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia","volume":"177","author":"Leucht","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0119","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/schbul\/sbv037","article-title":"Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method","volume":"41","author":"Leucht","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/schbul\/sbu001","article-title":"Dose equivalents for second-generation antipsychotics: the minimum effective dose method","volume":"40","author":"Leucht","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0121","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jpeds.2018.12.033","article-title":"A comparison of pediatric and adult safety studies for antipsychotic and antidepressant drugs submitted to the united states food and drug administration","volume":"208","author":"Liu","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0122","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/a-1854-0185","article-title":"Pharmacological treatment of early-onset schizophrenia: a critical review, evidence-based clinical guidance and unmet needs","volume":"55","author":"Lopez-Morinigo","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0123","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0124","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.eurpsy.2008.03.005","article-title":"Association between age at onset and clinical features of schizophrenia: the Northern Finland 1966 birth cohort study","volume":"23","author":"Luoma","year":"2008","journal-title":"Eur. Psychiatry J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0125","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/schbul\/sby119","article-title":"Hallucinations in children and adolescents: an updated review and practical recommendations for clinicians","volume":"45","author":"Maijer","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0126","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/eip.12682","article-title":"Survey of the European Psychiatric Association on the European status and perspectives in early detection and intervention in at-risk mental state and first-episode psychosis","volume":"13","author":"Maric","year":"2019","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0127","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jaac.2013.02.008","article-title":"Practice parameter for the assessment and treatment of children and adolescents with schizophrenia","volume":"52","author":"McClellan","year":"2013","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0128","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/0269881115576688","article-title":"Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms","volume":"29","author":"McCutcheon","year":"2015","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0129","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/j.1440-1614.2006.01860.x","article-title":"Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions","volume":"40","author":"McGorry","year":"2006","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0130","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.5694\/j.1326-5377.2007.tb01335.x","article-title":"Clinical staging: a heuristic model for psychiatry and youth mental health","volume":"187","author":"McGorry","year":"2007","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0131","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/jamapsychiatry.2018.0621","article-title":"Early intervention-an implementation challenge for 21st century mental health care","volume":"75","author":"McGorry","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0132","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/ipm.2015.2","article-title":"Who is in the transition gap? Transition from CAMHS to AMHS in the Republic of Ireland","volume":"32","author":"McNicholas","year":"2015","journal-title":"Ir. J. Psychol. Med."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2021.102005","article-title":"Preventive interventions for individuals at ultra high risk for psychosis: an updated and extended meta-analysis","volume":"86","author":"Mei","year":"2021","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0134","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.euroneuro.2014.03.008","article-title":"Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment","volume":"24","author":"Millan","year":"2014","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0135","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1176\/appi.ajp.2008.07111713","article-title":"Relationship of cognition and psychopathology to functional impairment in schizophrenia","volume":"165","author":"Mohamed","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0136","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jamapsychiatry.2020.4614","article-title":"Factors associated with real-life functioning in persons with schizophrenia in a 4-year follow-up study of the italian network for research on psychoses","volume":"78","author":"Mucci","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0137","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/jhm.12905","article-title":"Acute medical workup for new-onset psychosis in children and adolescents: a retrospective cohort","volume":"17","author":"Muhrer","year":"2022","journal-title":"J. Hosp. Med."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0138","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.schres.2007.09.001","article-title":"Subjective and objective quality of life in schizophrenia","volume":"98","author":"Narvaez","year":"2008","journal-title":"Schizophr. Res."},{"issue":"4 Suppl 1","key":"10.1016\/j.euroneuro.2024.02.005_bib0139","first-page":"S1","article-title":"Differential diagnosis and therapeutic management of schizoaffective disorder","volume":"22","author":"Nasrallah","year":"2010","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0140","series-title":"Transition from Children's to adults\u2019 Services For Young People Using Health Or Social Care Services","year":"2016"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0141","unstructured":"National Institute of Health and Care Excellence, 2013. Psychosis and schizophrenia in children and young people: recognition and management - NICE Clinical guideline CG155."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0142","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1192\/bjp.2023.27","article-title":"Optimising plasma clozapine levels to improve treatment response: an individual patient data meta-analysis and receiver operating characteristic curve analysis","volume":"222","author":"Northwood","year":"2023","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.euroneuro.2024.02.005_bib0144","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/schbul\/sbr084","article-title":"Neurocognitive predictors of work outcome in recent-onset schizophrenia","volume":"37","author":"Nuechterlein","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0145","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1192\/j.eurpsy.2021.2260","article-title":"Early intervention in psychosis services: a systematic review and narrative synthesis of the barriers and facilitators to implementation","volume":"65","author":"O'Connell","year":"2021","journal-title":"Eur. Psychiatry J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0146","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1037\/a0020855","article-title":"Neurocognition and functional outcome in early-onset schizophrenia and attention-deficit\/hyperactivity disorder: a 13-year follow-up","volume":"25","author":"Oie","year":"2011","journal-title":"Neuropsychology"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0147","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-0447.2012.01913.x","article-title":"Changes in the diagnosed incidence of early onset schizophrenia over four decades: incidence of early onset schizophrenia","volume":"127","author":"Okkels","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0150","first-page":"295","article-title":"Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants","volume":"21","author":"Ostuzzi","year":"2022","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0151","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S2215-0366(22)00158-4","article-title":"Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis","volume":"9","author":"Ostuzzi","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0154","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1192\/bjp.bp.110.084384","article-title":"Neurodevelopmental hypothesis of schizophrenia","volume":"198","author":"Owen","year":"2011","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0155","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaac.2021.11.032","article-title":"Early antipsychotic nonresponse as a predictor of nonresponse and nonremission in adolescents with psychosis treated with aripiprazole or quetiapine: results from the tea trial","volume":"61","author":"Pagsberg","year":"2022","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0156","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaac.2016.12.013","article-title":"Acute antipsychotic treatment of children and adolescents with schizophrenia-spectrum disorders: a systematic review and network meta-analysis","volume":"56","author":"Pagsberg","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2024.02.005_bib0157","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13034-022-00515-5","article-title":"Long-term methylphenidate use for children and adolescents with attention deficit hyperactivity disorder and risk for depression, conduct disorder, and psychotic disorder: a nationwide longitudinal cohort study in South Korea","volume":"16","author":"Park","year":"2022","journal-title":"Child Adolesc. Psychiatry Ment. Health"},{"issue":"5","key":"10.1016\/j.euroneuro.2024.02.005_bib0158","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/cap.2009.0051","article-title":"Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality","volume":"19","author":"Penzner","year":"2009","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0159","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0160","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.662093","article-title":"Neurodevelopmental trajectories and clinical profiles in a sample of children and adolescents with early- and very-early-onset schizophrenia","volume":"12","author":"Pontillo","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0161","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11414-007-9080-4","article-title":"US patterns of mental health service utilization for transition-age youth and young adults","volume":"35","author":"Pottick","year":"2008","journal-title":"J. Behav. Health Serv. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0162","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaac.2014.05.012","article-title":"Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial","volume":"53","author":"Puig","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0163","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00787-012-0262-0","article-title":"Processing speed and executive functions predict real-world everyday living skills in adolescents with early-onset schizophrenia","volume":"21","author":"Puig","year":"2012","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0164","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1097\/MJT.0000000000000894","article-title":"Off-label use of clozapine in children and adolescents-a literature review","volume":"26","author":"Rachamallu","year":"2019","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0165","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1192\/bjp.bp.108.060723","article-title":"Age at onset and cognition in schizophrenia: meta-analysis","volume":"195","author":"Rajji","year":"2009","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0166","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/eip.12502","article-title":"Negative symptoms in first-episode psychosis: clinical correlates and 1-year follow-up outcomes in London Early Intervention Services","volume":"13","author":"Rammou","year":"2019","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0167","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.mp.4001642","article-title":"The neurodevelopmental model of schizophrenia: update 2005","volume":"10","author":"Rapoport","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0168","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2009.09040574","article-title":"Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study","volume":"167","author":"Reichenberg","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0169","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1753-2000-2-6","article-title":"The psychopathological and psychosocial outcome of early-onset schizophrenia: preliminary data of a 13-year follow-up","volume":"2","author":"Reichert","year":"2008","journal-title":"Child Adolesc. Psychiatry Ment. Health"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0170","article-title":"The black hole of the transition process: dropout of care before transition age in adolescents","author":"Reneses","year":"2022","journal-title":"Eur. Child Adolesc. Psychiatry."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0171","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.biopsych.2005.04.031","article-title":"Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates","volume":"58","author":"Rhinewine","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0172","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/schbul\/sbac053","article-title":"Outcomes during and after early intervention services for first-episode psychosis: results over 5 years from the RAISE-ETP site-randomized trial","volume":"48","author":"Robinson","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0173","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1176\/appi.ps.201800511","article-title":"Predictors of hospitalization of individuals with first-episode psychosis: data from a 2-year follow-up of the RAISE-ETP","volume":"70","author":"Robinson","year":"2019","journal-title":"Psychiatr. Serv. Wash. DC"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0174","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40263-023-01009-4","article-title":"Early non-response to antipsychotic treatment in schizophrenia: a systematic review and meta-analysis of evidence-based management options","volume":"37","author":"Rubio","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0175","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/schbul\/sbab063","article-title":"Long-term continuity of antipsychotic treatment for schizophrenia: a nationwide study","volume":"47","author":"Rubio","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0176","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/sjop.12414","article-title":"The research evidence for schizophrenia as a neurodevelopmental disorder","volume":"59","author":"Rund","year":"2018","journal-title":"Scand. J. Psychol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0177","article-title":"What is the duration of untreated psychosis worldwide? A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies and 57,715 Individuals","author":"Salazar de Pablo","year":"2023","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.euroneuro.2024.02.005_bib0178","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jamapsychiatry.2021.0830","article-title":"Probability of transition to psychosis in individuals at clinical high risk: an updated meta-analysis","volume":"78","author":"Salazar de Pablo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0179","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/appi.ajp.2015.14101329","article-title":"Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review","volume":"172","author":"Samara","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2024.02.005_bib0180","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bdi.12340","article-title":"Test-retest reliability of schizoaffective disorder compared with schizophrenia, bipolar disorder, and unipolar depression\u2013a systematic review and meta-analysis","volume":"17","author":"Santelmann","year":"2015","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.euroneuro.2024.02.005_bib0181","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/bdi.12388","article-title":"Diagnostic shift in patients diagnosed with schizoaffective disorder: a systematic review and meta-analysis of rediagnosis studies","volume":"May;18","author":"Santelmann","year":"2016","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0182","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/YCO.0b013e32835dcc2a","article-title":"Treatment of adolescents with early-onset schizophrenia spectrum disorders: in search of a rational, evidence-informed approach","volume":"26","author":"Schimmelmann","year":"2013","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0183","first-page":"1","article-title":"Systematic review of the efficacy and tolerability of clozapine in the treatment of youth with early onset schizophrenia","volume":"29","author":"Schneider","year":"2014","journal-title":"Eur. Psychiatry J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0184","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(21)01997-8","article-title":"Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis","volume":"399","author":"Schneider-Thoma","year":"2022","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0185","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0269881116636107","article-title":"BAP Position Statement: off-label prescribing of psychotropic medication to children and adolescents","volume":"30","author":"Sharma","year":"2016","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0186","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114656","article-title":"Aerobic exercise and cognitive functioning in schizophrenia: an updated systematic review and meta-analysis","volume":"314","author":"Shimada","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0187","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1017\/S0033291721003901","article-title":"Effect of managed transition on mental health outcomes for young people at the child-adult mental health service boundary: a randomised clinical trial","volume":"53","author":"Singh","year":"2023","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0188","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.2021.61","article-title":"Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis","volume":"220","author":"Siskind","year":"2022","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0189","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.scog.2015.05.002","article-title":"Insight and subjective measures of quality of life in chronic schizophrenia","volume":"2","author":"Siu","year":"2015","journal-title":"Schizophr. Res. Cogn."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0190","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.chc.2019.08.010","article-title":"First episode psychosis medical workup: evidence-informed recommendations and introduction to a clinically guided approach","volume":"29","author":"Skikic","year":"2020","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0191","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1017\/S0033291719002083","article-title":"Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies","volume":"51","author":"Smart","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0192","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1089\/cap.2021.0027","article-title":"Psychotropic drug prescription in children and adolescents: approved medications in european countries and the United States","volume":"32","author":"Smogur","year":"2022","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0193","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41380-022-01727-z","article-title":"Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence","volume":"28","author":"Solmi","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0194","first-page":"214","article-title":"Safety of 80 antidepressants, antipsychotics, anti-attention-deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects","volume":"19","author":"Solmi","year":"2020","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0195","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/TCRM.S117321","article-title":"Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review","volume":"13","author":"Solmi","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0196","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","article-title":"Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies","volume":"27","author":"Solmi","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0197","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00787-015-0725-1","article-title":"Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial","volume":"24","author":"Stentebjerg-Olesen","year":"2015","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0198","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/cap.2013.0007","article-title":"Early nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychotics","volume":"23","author":"Stentebjerg-Olesen","year":"2013","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0199","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1089\/cap.2015.0097","article-title":"Clinical characteristics and predictors of outcome of schizophrenia-spectrum psychosis in children and adolescents: a systematic review","volume":"26","author":"Stentebjerg-Olesen","year":"2016","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2024.02.005_bib0200","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies","volume":"5","author":"Storeb\u00f8","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0202","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1089\/cap.2020.0030","article-title":"Time to clinical response in the treatment of early onset schizophrenia spectrum disorders study","volume":"31","author":"Taylor","year":"2021","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.euroneuro.2024.02.005_bib0203","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1017\/S1461145712001320","article-title":"Prevalence and predictors of antipsychotic polypharmacy in children and adolescents","volume":"17","author":"Toteja","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0204","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1192\/bjp.185.3.215","article-title":"Age at onset and cognitive functioning in schizophrenia","volume":"185","author":"Tuulio-Henriksson","year":"2004","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.schres.2009.03.035","article-title":"Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis","volume":"113","author":"Ventura","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0206","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.schres.2020.03.045","article-title":"Long-term outcome of early-onset compared to adult-onset schizophrenia: a nationwide Danish register study","volume":"220","author":"Vernal","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0207","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1176\/appi.ajp.2009.09010017","article-title":"The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia","volume":"166","author":"Vinogradov","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0208","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamapsychiatry.2021.0620","article-title":"Effectiveness, core elements, and moderators of response of cognitive remediation for schizophrenia: a systematic review and meta-analysis of randomized clinical trials","volume":"78","author":"Vita","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2024.02.005_bib0209","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaac.2017.01.016","article-title":"Psychotic symptoms in attention-deficit\/hyperactivity disorder: an analysis of the MTA database","volume":"56","author":"Vitiello","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0210","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/schbul\/sbaa060","article-title":"Clozapine combination and augmentation strategies in patients with schizophrenia -recommendations from an international expert survey among the treatment response and resistance in psychosis (TRRIP) working group","volume":"46","author":"Wagner","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0211","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.schres.2018.07.013","article-title":"A meta-analysis of factors associated with quality of life in first episode psychosis","volume":"202","author":"Watson","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0212","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.biopsych.2006.01.002","article-title":"Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects","volume":"60","author":"White","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0213","first-page":"1021","article-title":"Relationship between clozapine dose, serum concentration, and clinical outcome in children and adolescents in clinical practice","volume":"123","author":"Wohkittel","year":"2016","journal-title":"J. Neural Transm. Vienna Austria 1996"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0214","year":"2017","journal-title":"Depression and Other Common Mental Disorders: Global Health Estimates"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.schres.2007.03.030","article-title":"Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial","volume":"94","author":"Wykes","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0216","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12888-020-2484-x","article-title":"Predictors of outcome in early onset schizophrenia: a 10-year follow-up study","volume":"20","author":"Xu","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0217","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00406-009-0046-9","article-title":"Neuropsychological functioning in early-onset first-episode psychosis: comparison of diagnostic subgroups","volume":"260","author":"Zabala","year":"2010","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2024.02.005_bib0218","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.euroneuro.2017.06.011","article-title":"How well do patients with a first episode of schizophrenia respond to antipsychotics: a systematic review and meta-analysis","volume":"27","author":"Zhu","year":"2017","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24000403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24000403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T17:51:13Z","timestamp":1727113873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X24000403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":208,"alternative-id":["S0924977X24000403"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.02.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and treatment of individuals with childhood-onset and early-onset schizophrenia","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}